Resources and information for improving preventative healthcare for rabbits in practice, now made easier with Nobivac Myxo-RHD PLUS.
Triple Protection, One Vaccine
Until now, current practice required two annual vaccines to protect rabbits against myxomatosis and both strains of Rabbit Haemorrhagic Disease: RHDV-1 and RHDV-2.
Learn about the history and technology behind the new vaccine which now provides triple protection in one convenient vaccine.
Nobivac Myxo-RHD PLUS
Based on a novel combination of two live myxoma-vectored RHD viruses each containing nucleic acid of the capid VP60 gene from either RHDV-1 or RHDV-2
For full product information including presentation and active ingredients, click the link below.
Due to the phenomenon of vector interference, not all rabbits can be directly switched to Nobivac Myxo-RHD PLUS.
Read our guidance on how to switch rabbits to the new vaccine.
Frequently Asked Questions
Our FAQ page provides answers to the commonly asked questions about the new vaccine.
Click here to see if your questions are covered.
With the widespread ocurence of RHDV-2 it is more important than ever that pet rabbits are covered.
These serious and widespread diseases put both domestic and wild rabbits at risk of high morbidity and mortality.
Despite being a very popular pet in the UK, the welfare needs of rabbits are commonly misunderstood.
Our client support page provides first hand advice for rabbit owners on feeding, housing and transporting their rabbits to practice, to help keep pet rabbits happy and healthy.
Nobivac® Myxo-RHD PLUS contains live myxoma vectored RHD virus strain 009 and MK 1898. POM-V
MSD Animal Health UK Limited. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942.
Further information is available from the SPC, Datasheet or package leaflet. Advice should be sought from the medicine prescriber.
Use medicines responsibly